The worst is over for beleaguered tourism and aviation firms as Phase 3 Covid-19 vaccine trials draw to their conclusion with the end of the year. While herd immunity (i.e. 70% population immunity) will likely have to wait until 2023, such counters will likely enjoy a “higher-low” pullback in stock prices as the global population is slowly immunised from the coronavirus. 

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply